<DOC>
	<DOCNO>NCT00789698</DOCNO>
	<brief_summary>Lurasidone HCl compound develop treatment schizophrenia . This clinical study design test hypothesis lurasidone effective , tolerable , safe compare quetiapine XR long term among schizophrenic outpatient chronic schizophrenia .</brief_summary>
	<brief_title>Lurasidone HCl - A Long Term Phase 3 Study Patients With Chronic Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Lurasidone Hydrochloride</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Entry Criteria : Screening present study take place subject ' participation Study D1050233 complete , provide informed consent . Completed required assessment final study visit Study D1050233 . Suitable treatment outpatient set . Any chronic organic disease CNS ( schizophrenia ) . Considered investigator imminent risk suicide injury self , others , property .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>SM-13496</keyword>
	<keyword>Latuda</keyword>
	<keyword>Lurasidone</keyword>
</DOC>